The Telangana Government has recently announced that six pharma companies have come forward to establish green pharma units and expand their operations in the Green Pharma City.

The firms namely, MSN Group, Laurus Labs, Gland Pharma, Dr Reddy’s Laboratories, Aurobindo Pharma and Hetero Labs, signed MoUs with the state government in the presence of Chief Minister A Revanth Reddy.

These companies will invest around INR 5,620 crore and create 12,490 jobs. The government has agreed to allot land to these companies in Green Pharma City.

As per the MoUs, the MSN Group will establish a manufacturing unit and an R&D centre and Aurobindo Pharma and Laurus Labs will set up formulation units. At the same time, Gland Pharma will build an R&D centre as well as injectable drug substance manufacturing units.

Dr Reddy's Labs Director Satish Reddy, Laurus Labs ED V.V. Ravikumar, Gland Pharma CEO Srinivas, MSN Labs CMD M.S.N. Reddy, Aurobindo Pharma Director Madan Mohan Reddy, and Hetero Group Managing Director B. Vamsi Krishna, Telangana State Industrial Infrastructure Corporation (TSIIC) Chairperson Nirmala Jagga Reddy, Special Secretary to the Chief Minister, Ajith Reddy, and Special Chief Secretary, Industries Department, Jayesh Ranjan participated in the meeting.

Dr Reddy’s Laboratories will set up an injectable and biosimilars unit, while Hetero Labs will establish a finishing dose and injectable drug manufacturing unit.

The Chief minister directed officials to expedite the land allotment process and provide necessary facilities to ensure that construction works begin within the next four months.